You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nonmyeloablative conditioning.

Showing 26 - 50 of 1,422
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Samples and Data for National Marrow Donor Program Repository

Recruiting
  • Bone Marrow Transplantation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 1, 2022

    Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

    Recruiting
    • Sickle Cell Anemia
    • Beta Thalassemia
    • TBI
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Diffuse Cutaneous Systemic Sclerosis Trial in Ann Arbor (FCR001)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • FCR001
    • Ann Arbor, Michigan
      University of Michigan
    Mar 4, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Jan 25, 2022

    Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)

    Completed
    Has Results
    • Acute Leukemia
    • +4 more
    • Atlanta, Georgia
      Northside Hospital
    Sep 1, 2021

    Adult Lymphoblastic Lymphoma Trial in Birmingham (Fludarabine, Total Body Irradiation)

    Completed
    Has Results
    • Adult Lymphoblastic Lymphoma
    • Birmingham, Alabama
      UAB Bone Marrow Transplantation and Cellular Therapy Program
    Aug 23, 2022

    Leukemia, Myeloid, Leukemia, Acute Myeloid Leukemia (AML) Trial in United States (procedure, drug, radiation)

    Terminated
    Has Results
    • Leukemia, Myeloid
    • +2 more
    • Allogeneic HSCT
    • +6 more
    • Hayward, California
    • +4 more
    Sep 11, 2019

    Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Stem cell infusion
    • +5 more
    • Saint Louis, Missouri
      Washington University
    Jan 17, 2023

    Sickle Cell Disease Trial in Duarte (drug, procedure, radiation)

    Recruiting
    • Sickle Cell Disease
    • Duarte, California
      City of Hope Comprehensive Cancer Center
    Jul 31, 2022

    Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

    Completed
    • Chronic Myelogenous Leukemia
    • +9 more
    • Atlanta, Georgia
      Northside Hospital
    Apr 4, 2022

    Hematologic Tumors Trial in Milan (Cyclophosphamide, Hematopoietic Stem Cell Transplantation,)

    Recruiting
    • Hematologic Neoplasms
    • Milan, Italy
      European Institute of Oncology
    Sep 24, 2021

    Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan

    Active, not recruiting
    • Myeloid Malignancies
    • +4 more
    • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
    • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Feb 25, 2022

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

    Terminated
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +9 more
    • Allogeneic Bone Marrow Transplantation
    • +7 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 4, 2021

    Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

    Recruiting
    • Chronic Granulomatous Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 23, 2022

    Myelodysplastic Syndrome, Myeloproliferative Tumors, Chronic Myelomonocytic Leukemia Trial in United States (other, drug,

    Recruiting
    • Myelodysplastic Syndrome
    • +4 more
    • Geriatric assessment (GA) pre-transplant
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Aug 24, 2022

    Sickle Cell Disease and Thalassemia Trial in Dallas (Donor Stem Cell Transplantation)

    Withdrawn
    • Sickle Cell Disease and Thalassemia
    • Donor Stem Cell Transplantation
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 22, 2021

    Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Aug 16, 2022

    Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

    Recruiting
    • Lymphoid Leukemia, Acute
    • +2 more
    • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc
    May 24, 2022

    Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

    Active, not recruiting
    Has Results
    • Sickle Cell Anemia
    • PBSC Transplant
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 13, 2022

    Inherited Immune Deficiencies Trial run by the NIAID (Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG))

    Completed
    Has Results
    • Inherited Immune Deficiencies
    • Campath 1H
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 20, 2021

    Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies Trial in Canada, United States (Treatment

    Recruiting
    • Metabolic Disorders
    • +3 more
    • Treatment Plan 1: Stratum 1
    • +3 more
    • Phoenix, Arizona
    • +19 more
    Oct 12, 2021

    Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,

    Recruiting
    • Primary T-cell Immunodeficiency Disorders
    • +4 more
    • Immunosuppression Only Conditioning -Closed with amendment L
    • +4 more
    • Bethesda, Maryland
    • +1 more
    Jul 26, 2022

    Hematopoietic Stem Cell Transplantation for Treatment of

    Recruiting
    • Multiple Sclerosis
    • Multiple Sclerosis, Relapsing-Remitting
    • Autologous hematopoietic stem cell transplantation
    • Gothenburg, Sweden
    • +7 more
    Feb 7, 2022

    Acute Myeloid Leukemia and Myelodysplastic Syndrome Trial in Hackensack (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Acute Myeloid Leukemia and Myelodysplastic Syndrome
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Aug 5, 2022

    Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Denmark, Italy, United

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • +8 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Rochester, Minnesota
    • +4 more
    Jun 20, 2019